We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/4/2018 08:32 | A last minute offer would be dull. Not long left now. | mbmiah | |
13/4/2018 08:28 | Maybe the banks are doing a credit checks on takeda | mbmiah | |
13/4/2018 08:16 | Don't worry, the drop is part of the take over strategy! Big share holders who want SHP to be taken over will make sure share price does not run ahead of itself and the offer from Takeda remains attractive when it comes. | karateboy | |
13/4/2018 08:08 | Wasn't expecting a drop here. It is Friday I guess lol | mbmiah | |
13/4/2018 07:34 | Takeda share price has started a new leg down - great :) | ruethewhirl | |
12/4/2018 23:51 | To me the real fire work starts if any other suitor gets into the ring which is 'highly likely' . With that sort of low interest Takeda can borrow a bit more to exchange current Shire debts . | karateboy | |
12/4/2018 23:42 | Market report: .... takeover target Shire Pharmaceuticals rallied a further 96p to £36.86 amid numerous reports that Japanese suitor Takeda has approached lenders to finance a mega deal which City analysts believe could hit the £35bn mark. Although pharma peer Takeda has pledged to maintain its dividend and credit rating, reports in Japan have indicated that it is seeking to lend tens of billions of dollars to fund a swoop for the FTSE 100 company. Shire shares have been in the ascendancy since Takeda revealed its interest last month but doubts have been raised over the Osaka company’s ability to finance a swoop without placing further strain on its stretched balance sheet. | philanderer | |
12/4/2018 19:08 | The board don't need to be approached per say. It is the shareholders who will ultimately vote on it as such the largest share holders may have been sounded out. The first question the banks would ask is how much do you need. | blueclyde | |
12/4/2018 19:04 | It would also be interesting to see how much another company values shire. I mean, the brokers haven't a clue either way. | mbmiah | |
12/4/2018 18:38 | The BOD need to declare the verbal offer then. It must have been made informally but as usual not declared to PI's. | justiceforthemany | |
12/4/2018 18:02 | I imagine that if they are approaching banks then they have already approached the major shareholders to sound out if this is worth while and a price that is going to get a deal done. You need to factor in folks that the 10 year Japanese Government bond has a yield of 0%. They will be able to borrow at very attractive rates and as we can see Shire is very cash generative whilst still having a lot of products in the pipeline. I believe a deal will be done at a decent price. | blueclyde | |
12/4/2018 14:43 | Can't see how they can afford to make an acceptable offer without a Neuroscience spin-off being part of the deal. | romeike | |
12/4/2018 14:39 | Just back to where we were last friday night :-) | philanderer | |
12/4/2018 14:35 | SMALL TAKE OFF | demo trader | |
12/4/2018 14:33 | A bit of a boost as the US opens ? | philanderer | |
12/4/2018 14:32 | It is coming soon :-) , Initially 4000p, IMO | demo trader | |
12/4/2018 12:09 | As BillyTK posted "..Shire was the standout gainer amid reports that Japan’s Takeda has sounded out creditors for loans as it moves closer to making a bid for the group." | philanderer | |
12/4/2018 09:23 | Good find BTK , morning everyone | philanderer | |
11/4/2018 16:22 | Just thirteen days for Takeda to come up with a number, and a few more bailing out than buying today | philanderer | |
11/4/2018 15:15 | Phil, thanks for the link. Lindsell is a well respected fund manager. Yes it is a concern that a higher debt company takes over /merge with Shire. However, as Lindsell pointed out "sell off incompatible expertise, more debt", also Takeda wants to expands in the US market where Shire already has a good position. I think these options are feasible to aid Takeda's acquisition of Shire as debt in Japan is dirt cheap. | compnews1 | |
11/4/2018 14:49 | ADR up nearly a 1%..... what's going on, hmmmm | mbmiah | |
11/4/2018 12:30 | Nice to see some support this morning anyway :-) | philanderer | |
11/4/2018 10:01 | Yep, talk about the calm before the storm. There will be a double digit percentage move up or down depending on what is decided. | ruethewhirl |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions